Safety, Pharmacokinetics (PK), and Efficacy of ONC-841 in Advanced Solid Tumors
-
Enrollment
This study is currently enrolling. -
Associated Conditions
-
Research Area
Clinical Cancer Research -
Location
-
Principal Investigator
-
Sponsor
OncoC4 Inc
This is a research study to find out if an experimental drug called ONC-841 is safe and effective in cancer patients and how the drug is absorbed and processed in the body of patients with cancer. ONC-841 is an antibody drug that is designed to regulate the immune system to try to treat cancer.
Enrollment Form
This study is currently enrolling.